Chronic effects on the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation treated with amiodarone, segmental pulmonary vein ablation, or amiodarone plus losartan: a prospective cohort study.
- Author:
Zhi-yu LING
1
;
Xian-bin LAN
;
Li SU
;
Zeng-chang LIU
;
Jin-jin WU
;
Dong LIU
;
Yun-qing CHEN
;
Xiao-yu YANG
;
Qiang SHE
;
Kai-liang LUO
;
Bernhard ZRENNER
;
Yue-hui YIN
Author Information
- Publication Type:Journal Article
- MeSH: Aged; Amiodarone; therapeutic use; Anti-Arrhythmia Agents; therapeutic use; Atrial Fibrillation; prevention & control; therapy; Catheter Ablation; methods; Combined Modality Therapy; Follow-Up Studies; Humans; Losartan; therapeutic use; Middle Aged; Prospective Studies; Treatment Outcome
- From: Chinese Journal of Cardiology 2007;35(9):822-826
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVEThis study was designed to compare clinical efficacy of segmental pulmonary vein ablation (SPVI), amiodarone or amiodarone plus losartan on sinus rhythm maintenance in patients with lone paroxysmal atrial fibrillation (PAF).
METHODSPatients with lone PAF were treated with amiodarone alone (A, n = 52), segmental pulmonary vein isolation (SPVI, n = 51), or amiodarone plus losartan (AL, n = 51). The primary endpoint of this study was the incidence of symptomatic atrial tachyarrhythmia (> 30 s) documented by 12 lead ECG or Holter during 12 months follow-up period.
RESULTSDuring follow-up, AF was documented in 24 patients (46.2%) in A group, 11 patients (21.6%) in SPVI group and 12 (23.5%) in AL group (P < 0.05 vs. A group). The Kaplan-Meier survival analysis demonstrated a significant equally reduction in AF recurrence in SPVI and AL groups (P = 0.009, log-rank test and P = 0.018, log-rank test, respectively) compared with A group. The hazard ratio for AF recurrence in patients treated with SPVI and amiodarone plus losartan was 0.41 (95% CI 0.200 to 0.848, P = 0.016) and 0.46 (95% CI 0.225 to 0.953, P = 0.036), respectively. Incidences of major adverse cardiac events were similar among the groups (9.6% in A, 3.9% in SPVI and 7.8% in AL group, P > 0.05).
CONCLUSIONThe results of this study suggest that the segmental pulmonary vein isolation and amiodarone plus losartan are superior to amiodarone alone for preventing AF recurrence in patients with lone PAF.